Inauguration Day 2021 began like no other. A ring of steel and tens of thousands of National Guard troops surround Washington DC for the swearing-in of Joe Biden and Kamala Harris, following the insurrection at the US Capitol earlier this month by a pro-Trump mob.
The outgoing president broke with 150 years of tradition and refused to welcome his successor and be present for the peaceful transfer of power at noon. Instead, Mr Trump jetted off on Air Force One for his new life in Florida early Wednesday. Here, The Independent follows the day as it unfolds.
The Arizona Diamondbacks have uncertainty in their bullpen this spring and essentially every role is up for grabs. Veteran right-hander Tyler Clippard is completely fine with that situation. Clippard was announced as a member of the Diamondbacks on Friday, four days after he agreed to terms on a $2.25 million, one-year contract.
Shares of Carnival (NYSE: CCL), the biggest of the American cruise lines, dropped yesterday along with those of all its peers when investors were disappointed by Norwegian Cruise Line Holdings' (NYSE: NCLH) earnings announcement. Today, Carnival stock is moving back up -- 3.8% higher as of 3 p.m. EST -- and probably also because of Norwegian. Cruise stocks had a rough 2020, and a rough start to 2021 as well, as the pandemic and recession continue to take their toll as their cruise ships remain locked in port.
Shares of DraftKings (NASDAQ: DKNG) rose on Friday, following the release of its fourth-quarter results. DraftKings' revenue soared 146% year over year to $322 million. The gains were fueled by a 44% surge in monthly unique paying customers, to an average of 1.5 million, and a 55% jump in average revenue per payer.
Shares of LivePerson (NASDAQ: LPSN) have soared today, up by 15% as of 2:45 p.m. EST, after the company reported fourth-quarter earnings. Revenue in the fourth quarter increased 29% to $102.1 million, ahead of the consensus estimate of $99.2 million. The technology company, which specializes in conversational commerce software, said that it inked 128 new contracts during the quarter, including 10 deals worth over $1 million.
TikTok users are experimenting with duck calls and they're getting really weird with it. The post What is the Duck Call Challenge on TikTok? The latest trend is delightfully unhinged appeared first on In The Know.
ABC News is premiering a six-episode series on Tuesday that is being promoted as something far different for traditional network newsmagazine: Soul of a Nation focuses on the Black experience in America, or as ABC News executive Marie Nelson put it on Friday, “The series expands the vision of Black life in America in a […]
The snow and ice rally, based in Rovaniemi, is the second round of the season and the first time the championship has ventured within the Arctic Circle. Tanak won the first stage by 3.6 seconds and was then almost 10 faster than anyone else in the next one run in the evening dark. "This has been a rollercoaster kind of day, typical for Finland with very technical and up-and-down roads," added the 2019 world champion.
Europe's medicines regulator on Friday provisionally approved use of US biotech firm Regeneron's Covid-19 therapy, saying it prevented patients from getting worse. Regeneron's synthetic antibody treatment was used to treat former US President Donald Trump after he contracted coronavirus last year.The European Medicines Agency said preliminary results showed treatment with REGN-COV2 reduced the amount of the virus in the back of the nose and throat and led to fewer medical visits."The Agency concluded that... REGN-COV2 can be used for the treatment of confirmed Covid-19 in patients who do not require supplemental oxygen and who are at high risk of progressing to severe Covid-19," it said in a statement.REGN-COV2 is a combination of casirivimab and imdevimab, two monoclonal antibodies which is given to a patient via a drip, the EMA said.Monoclonal antibodies are lab-made versions of the body's natural infection-fighting defenses.The two antibodies have been designed to attach to the spike protein of the coronavirus at two different sites, stopping it from entering the body's cells, the EMA said.A rolling review of the two antibodies, which started on February 1 "was ongoing", the medicines regulator said, adding "once finalised it will be the basis for an EU marketing authorisation for this combination".The US-based Food and Drug Administration in November approved emergency use of REGN-COV2, experimentally used to treat Trump.On Thursday, France too announced it had distributed thousands of monoclonal antibody treatments to hospitals, with Health Minister Olivier Veran saying "there are new hopes... which strengthen our anti-Covid arsenal".The EMA however did not make an announcement Friday on the approval of Johnson & Johnson's coronavirus jab, which earlier this month applied for authorisation within the European Union.So far, three vaccines made by Pfizer/BioNTech, Moderna and AstraZeneca have been approved by the EMA.A US panel of independent experts were meeting Friday to discuss whether to grant J&J's covid shot the go-ahead in the United States.Friday's announcements followed the Amsterdam-based EMA's monthly meeting, where it also recommended the approval of six other medicines including the first oral treatment for patients with certain types of spinal muscular atrophy.This rare and often fatal genetic disease causes muscle weakness and progressive loss of movement.(AFP)